Biograil is a startup based in Germany, most recent round Seed, 2 tracked investors.
Biograil is a company founded in 2025 headquartered in Germany. Its most recent tracked round is Seed. Brouky records 2 investors associated with the company.
Biograil develops an oral drug delivery device designed to enable the oral administration of large molecule drugs, which are typically given via injection. This technology aims to improve patient adherence and quality of life.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.